Jérôme Filippi

6.2k total citations
58 papers, 2.1k citations indexed

About

Jérôme Filippi is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Jérôme Filippi has authored 58 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Genetics, 32 papers in Epidemiology and 23 papers in Surgery. Recurrent topics in Jérôme Filippi's work include Inflammatory Bowel Disease (43 papers), Microscopic Colitis (31 papers) and Eosinophilic Esophagitis (7 papers). Jérôme Filippi is often cited by papers focused on Inflammatory Bowel Disease (43 papers), Microscopic Colitis (31 papers) and Eosinophilic Esophagitis (7 papers). Jérôme Filippi collaborates with scholars based in France, Switzerland and Netherlands. Jérôme Filippi's co-authors include Xavier Hébuterne, S. Schneider, Xavier Hébuterne, Rima Al-Jaouni, Laurent Peyrin‐Biroulet, Xavier Roblin, David Laharie, Raffaella Dainese, Marie‐Christine Saint‐Paul and Stéphane Nancey and has published in prestigious journals such as Gastroenterology, PLoS ONE and Gut.

In The Last Decade

Jérôme Filippi

56 papers receiving 2.1k citations

Peers

Jérôme Filippi
Robert Burakoff United States
Jérôme Filippi
Citations per year, relative to Jérôme Filippi Jérôme Filippi (= 1×) peers Robert Burakoff

Countries citing papers authored by Jérôme Filippi

Since Specialization
Citations

This map shows the geographic impact of Jérôme Filippi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme Filippi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme Filippi more than expected).

Fields of papers citing papers by Jérôme Filippi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérôme Filippi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme Filippi. The network helps show where Jérôme Filippi may publish in the future.

Co-authorship network of co-authors of Jérôme Filippi

This figure shows the co-authorship network connecting the top 25 collaborators of Jérôme Filippi. A scholar is included among the top collaborators of Jérôme Filippi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jérôme Filippi. Jérôme Filippi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fuméry, Mathurin, Stéphane Nancey, Jérôme Filippi, et al.. (2023). Effectiveness of golimumab intensification in ulcerative colitis: A multicentric prospective study. Alimentary Pharmacology & Therapeutics. 57(11). 1290–1298. 2 indexed citations
2.
Filippi, Jérôme, Jean Maccario, N. Neveux, et al.. (2021). Dose-dependent beneficial effects of citrulline supplementation in short bowel syndrome in rats. Nutrition. 85. 111118–111118. 7 indexed citations
3.
Laharie, David, Geert D’Haens, Maria Nachury, et al.. (2021). Steroid-Free Deep Remission at One Year Does Not Prevent Crohn's Disease Progression: Long-Term Data From the TAILORIX Trial. Clinical Gastroenterology and Hepatology. 20(9). 2074–2082. 15 indexed citations
4.
Stefănescu, Carmen, Franck Carbonnel, Laurent Peyrin‐Biroulet, et al.. (2018). Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis. Clinical Gastroenterology and Hepatology. 17(3). 494–501. 51 indexed citations
5.
Gelsi, Ève, Damien Van Gysel, Anne-Claire Frin, et al.. (2016). Assessment of D-Dimers for the Early Prediction of Complications in Acute Pancreatitis. Pancreas. 45(7). 980–985. 18 indexed citations
6.
Simon, M., Jacques Cosnes, J.M. Gornet, et al.. (2016). Endoscopic Detection of Small Bowel Dysplasia and Adenocarcinoma in Crohn’s Disease: A Prospective Cohort-Study in High-Risk Patients. Journal of Crohn s and Colitis. 11(1). 47–52. 19 indexed citations
7.
Depont, F., Francis Bérenbaum, Jérôme Filippi, et al.. (2015). Interventions to Improve Adherence in Patients with Immune-Mediated Inflammatory Disorders: A Systematic Review. PLoS ONE. 10(12). e0145076–e0145076. 37 indexed citations
8.
Piche, Thierry, et al.. (2014). Osteopathy decreases the severity of IBS-like symptoms associated with Crohn’s disease in patients in remission. European Journal of Gastroenterology & Hepatology. 26(12). 1392–1398. 16 indexed citations
9.
Vivinus-Nébot, Mylène, Hanene Bzioueche, Raffaella Dainese, et al.. (2013). Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation. Gut. 63(5). 744–752. 295 indexed citations
10.
Vanbiervliet, Geoffroy, Jérôme Filippi, Nicolas Vénissac, et al.. (2011). The role of clips in preventing migration of fully covered metallic esophageal stents: a pilot comparative study. Surgical Endoscopy. 26(1). 53–59. 109 indexed citations
11.
Bouguen, Guillaume, Xavier Roblin, Arnaud Bourreille, et al.. (2010). Infliximab for refractory ulcerative proctitis. Alimentary Pharmacology & Therapeutics. 31(11). 1178–1185. 33 indexed citations
12.
Billioud, Vincent, David Laharie, Jérôme Filippi, et al.. (2010). Adherence to adalimumab therapy in Crohnʼs disease: A French multicenter experience. Inflammatory Bowel Diseases. 17(1). 152–159. 36 indexed citations
13.
Oussalah, Abderrahim, Ludovic Evesque, David Laharie, et al.. (2010). A Multicenter Experience With Infliximab for Ulcerative Colitis: Outcomes and Predictors of Response, Optimization, Colectomy, and Hospitalization. The American Journal of Gastroenterology. 105(12). 2617–2625. 146 indexed citations
14.
Oussalah, Abderrahim, Xavier Roblin, David Laharie, et al.. (2009). Tumour necrosis factor antagonists and inflammatory bowel diseases: a national practice survey. Alimentary Pharmacology & Therapeutics. 30(8). 854–863. 11 indexed citations
15.
Hébuterne, Xavier, Jérôme Filippi, Rima Al-Jaouni, & S. Schneider. (2009). Nutritional consequences and nutrition therapy in Crohn's disease. Gastroentérologie Clinique et Biologique. 33. S235–S244. 32 indexed citations
16.
Piche, T., Marie‐Christine Saint‐Paul, Raffaella Dainese, et al.. (2008). Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome. Gut. 57(4). 468–473. 155 indexed citations
17.
Schneider, S., Rima Al-Jaouni, Jérôme Filippi, et al.. (2008). Sarcopenia is prevalent in patients with Crohnʼs disease in clinical remission. Inflammatory Bowel Diseases. 14(11). 1562–1568. 116 indexed citations
18.
Filippi, Jérôme, et al.. (2007). Incidence of inflammatory bowel disease in Corsica from 2002 to 2003. Gastroentérologie Clinique et Biologique. 31(12). 1098–1103. 20 indexed citations
19.
Filippi, Jérôme, et al.. (2006). Nutritional deficiencies in patients with Crohnʼs disease in remission. Inflammatory Bowel Diseases. 12(3). 185–191. 208 indexed citations
20.
Filippi, Jérôme, S. Schneider, Rima Al-Jaouni, et al.. (2005). Muscle Performance in Patients With Crohnʼs Disease in Clinical Remission. Inflammatory Bowel Diseases. 11(3). 296–303. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026